World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   8098 records for 1656 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
AuthorisedYesEUCTR2016-004046-28-HR
A clinical study to assess the long-term safety and efficacy of Orelvo (voclosporin) compared with placebo in subjects with active lupus nephritis (LN)
13/04/2018 
AuthorisedYesEUCTR2017-002225-38-HR
A clinical study investigating the safety and tolerability of brexpiprazole in the Treatment of Subjects with Bipolar I Disorder
12/04/2018 
RecruitingYesNCT03495830
Stratification of Patient With Carotid Disease
21/03/2018 
Not recruitingYesNCT03466411
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
08/03/2018 
Not recruitingNoNCT03460782
An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas
05/03/2018 
Not AvailableYesEUCTR2017-003723-29-SE
A study of safety and efficacy of lenabasum in Cystic Fibrosis
01/03/2018 
Not RecruitingYesCTRI/2018/02/012091
Study to Assess the Efficacy and Safety of MB02 (Bevacizumab Biosimilar Drug) Versus Avastin® in Combination With Carboplatin and Paclitaxel for the Treatment of patients with Stage IIIB/IV Non-squamous Non-Small Cell Lung Cancer (NSCLC) 22-02-2018 
AuthorisedYesEUCTR2017-004293-33-LT
Multicenter Study of Oral Ozanimod as Induction Therapy in patients with Moderately to Severely Active Crohn’s Disease
01/02/2018 
AuthorisedYesEUCTR2017-004294-14-LT
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease
01/02/2018 
AuthorisedYesEUCTR2017-004295-55-LT
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease
01/02/2018 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history